Epigenetic Mechanisms of Postoperative Cognitive Impairment Induced by Anesthesia and Neuroinflammation

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Neurobiology and Clinical Neuroscience".

Deadline for manuscript submissions: 31 July 2024 | Viewed by 126

Special Issue Editor


E-Mail Website
Guest Editor
Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie, Knappschaftskrankenhaus Bochum, In der Schornau 23-25, 44892 Bochum, Germany
Interests: sepsis; sepsis therapy; cognitive dysfunction; subarachnoid hemorrhage; inflammation; glucocorticoids

Special Issue Information

Dear Colleagues,

The aim of this Special Issue is to gain a deeper view into the molecular mechanisms of cognitive impairment after surgery, which is a common problem that mainly affects the elderly and can be divided into postoperative delirium and postoperative cognitive dysfunction. Both phenomena are accompanied by neuroinflammation; however, the precise molecular mechanisms underlying cognitive impairment after anesthesia are not yet fully understood. Anesthetics can have a longer-term impact on protein transcription; thus, epigenetic alterations are a possible mechanism. Epigenetic mechanisms may be responsible for long-lasting effects and may implicate novel therapeutic approaches. Studies that focus on the impact of anesthetics on the expression of DNA and histone-modifying enzymes are welcome, as these can affect epigenetic markers, such as methylation, histone acetylation, and histone methylation.  As neuroinflammation is generally increased, studies could focus on inflammatory genes (e.g., TNF-alpha, IL-6, or IL1 beta) and genes that are responsible for neuronal development (such as brain-derived neurotrophic factor) could be examined. In addition, studies that focus on the development of novel therapeutic approaches are highly desired.

Dr. Rump Katharina
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cognitive impairment
  • postoperative delirium
  • postoperative cognitive dysfunction
  • neuroinflammation
  • DNA methyltransferase
  • HDAC. HAT
  • epigenetics
  • DNA methylation
  • histone modification
  • RNAi

Published Papers

This special issue is now open for submission.
Back to TopTop